These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 10402641)

  • 1. Preclinical experimental therapeutic approaches in soft tissue sarcoma.
    Hunt KK; Feig BW
    Semin Surg Oncol; 1999; 17(1):78-82. PubMed ID: 10402641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the understanding of human soft tissue sarcomas: molecular biology and therapeutic strategies (Review).
    Milas M; Yu D; Pollock RE
    Oncol Rep; 1998; 5(5):1275-9. PubMed ID: 9683850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soft tissue sarcoma in adults.
    Dirix LY; Van Oosterom AT
    Curr Opin Oncol; 1999 Jul; 11(4):285-95. PubMed ID: 10416881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus-mediated p53 gene therapy in pediatric soft-tissue sarcoma cell lines: sensitization to cisplatin and doxorubicin.
    Ganjavi H; Gee M; Narendran A; Freedman MH; Malkin D
    Cancer Gene Ther; 2005 Apr; 12(4):397-406. PubMed ID: 15618970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular targets in therapy for human soft-tissue and bone sarcomas.
    Steinert DM; Blakely LJ; Salganick J; Trent JC
    Curr Oncol Rep; 2003 Jul; 5(4):295-303. PubMed ID: 12781071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the diagnosis and management of sarcomas.
    Elias AD
    Curr Opin Oncol; 1992 Aug; 4(4):681-8. PubMed ID: 1511024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.
    Pollack SM; He Q; Yearley JH; Emerson R; Vignali M; Zhang Y; Redman MW; Baker KK; Cooper S; Donahue B; Loggers ET; Cranmer LD; Spraker MB; Seo YD; Pillarisetty VG; Ricciotti RW; Hoch BL; McClanahan TK; Murphy E; Blumenschein WM; Townson SM; Benzeno S; Riddell SR; Jones RL
    Cancer; 2017 Sep; 123(17):3291-3304. PubMed ID: 28463396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular determinants of soft tissue sarcoma proliferation.
    Pollock RE
    Semin Surg Oncol; 1994; 10(5):315-22. PubMed ID: 7997725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetics of soft tissue sarcomas.
    Cooper CS; Cornes P
    Cancer Treat Res; 1997; 91():31-50. PubMed ID: 9286487
    [No Abstract]   [Full Text] [Related]  

  • 10. The current reality of soft tissue sarcomas: advances, controversies, areas for improvement, and promising new treatments.
    Blay JY; Le Cesne A; Demetri GD
    Expert Rev Anticancer Ther; 2020 Apr; 20(sup1):29-39. PubMed ID: 32349562
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel Aspects of Genetics, Molecular Biology and Clinical Oncology of Sarcomas.
    Houfková K; Hatina J
    Klin Onkol; 2020; 33(1):66-78. PubMed ID: 32075391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental approaches to treatment of soft tissue sarcoma.
    Hwang RF; Hunt KK
    Surg Oncol Clin N Am; 2003 Apr; 12(2):499-521. PubMed ID: 12916466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in the recognition and treatment of soft tissue sarcomas.
    Eilber FR; Huth JF; Mirra J; Rosen G
    Cancer; 1990 Feb; 65(3 Suppl):660-6. PubMed ID: 2405992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [What is the value of recent molecular biology knowledge for surgical oncologic therapy of soft tissue sarcoma?].
    Willeke F
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():393-8. PubMed ID: 9931648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TP53 in bone and soft tissue sarcomas.
    Thoenen E; Curl A; Iwakuma T
    Pharmacol Ther; 2019 Oct; 202():149-164. PubMed ID: 31276706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncommon and peculiar soft tissue sarcomas: Multidisciplinary review and practical recommendations. Spanish Group for Sarcoma research (GEIS -GROUP). Part II.
    Martínez-Trufero J; Cruz Jurado J; Hernández-León CN; Correa R; Asencio JM; Bernabeu D; Alvarez R; Hindi N; Mata C; Marquina G; Martínez V; Redondo A; Floría LJ; Gómez-Mateo MC; Lavernia J; Sebio A; Garcia Del Muro X; Martin-Broto J; Valverde-Morales C
    Cancer Treat Rev; 2021 Sep; 99():102260. PubMed ID: 34340159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soft tissue sarcomas of the extremity and retroperitoneum: advances in management.
    Sondak VK; Economou JS; Eilber FR
    Adv Surg; 1991; 24():333-59. PubMed ID: 1996527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapeutic approaches to sarcoma.
    Linehan DC; Bowne WB; Lewis JJ
    Semin Surg Oncol; 1999; 17(1):72-7. PubMed ID: 10402640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic predictors for drug resistance in soft tissue sarcoma: a review of publications in 2004.
    Fayette J; Blay JY
    Curr Opin Oncol; 2005 Jul; 17(4):370-5. PubMed ID: 15933471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics of soft tissue tumors.
    van de Rijn M; Fletcher JA
    Annu Rev Pathol; 2006; 1():435-66. PubMed ID: 18039122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.